These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 8974063

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effects of ACE inhibition and angiotensin II type 1 receptor blockade on cardiac function and G proteins in rats with chronic heart failure.
    Yoshida H, Takahashi M, Tanonaka K, Maki T, Nasa Y, Takeo S.
    Br J Pharmacol; 2001 Sep; 134(1):150-60. PubMed ID: 11522607
    [Abstract] [Full Text] [Related]

  • 24. Angiotensin II type 2 receptor blockade partially negates antihypertrophic effects of type 1 receptor blockade on pressure-overload rat cardiac hypertrophy.
    Mukawa H, Toki Y, Miyazaki Y, Matsui H, Okumura K, Ito T.
    Hypertens Res; 2003 Jan; 26(1):89-95. PubMed ID: 12661917
    [Abstract] [Full Text] [Related]

  • 25. Enalapril prevents aortic hyperreactivity and remodelling in one-kidney, one-clip hypertensive rats without reducing arterial pressure.
    Cunha V, Salgado HC, Salgado MC.
    Clin Exp Pharmacol Physiol; 2000 Jul; 27(7):474-9. PubMed ID: 10874501
    [Abstract] [Full Text] [Related]

  • 26. Effects of an AT1 receptor antagonist, an ACE inhibitor and a calcium channel antagonist on cardiac gene expressions in hypertensive rats.
    Kim S, Ohta K, Hamaguchi A, Yukimura T, Miura K, Iwao H.
    Br J Pharmacol; 1996 Jun; 118(3):549-56. PubMed ID: 8762077
    [Abstract] [Full Text] [Related]

  • 27. Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats.
    Sanada S, Kitakaze M, Node K, Takashima S, Ogai A, Asanuma H, Sakata Y, Asakura M, Ogita H, Liao Y, Fukushima T, Yamada J, Minamino T, Kuzuya T, Hori M.
    Hypertension; 2001 Sep; 38(3):404-11. PubMed ID: 11566913
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis.
    Luo JD, Zhang WW, Zhang GP, Guan JX, Chen X.
    Clin Exp Pharmacol Physiol; 1999 Nov; 26(11):903-8. PubMed ID: 10561812
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Long-term angiotensin-converting enzyme inhibition with fosinopril improves depressed responsiveness to Ca2+ in myocytes from aortic-banded rats.
    Kagaya Y, Hajjar RJ, Gwathmey JK, Barry WH, Lorell BH.
    Circulation; 1996 Dec 01; 94(11):2915-22. PubMed ID: 8941121
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The effects of renin-angiotensin system inhibition on aortic cholesterol content in cholesterol-fed rabbits.
    Sugano M, Makino N, Yanaga T.
    Atherosclerosis; 1996 Nov 15; 127(1):123-9. PubMed ID: 9006812
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Angiotensin AT1 receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis.
    Weinberg EO, Lee MA, Weigner M, Lindpaintner K, Bishop SP, Benedict CR, Ho KK, Douglas PS, Chafizadeh E, Lorell BH.
    Circulation; 1997 Mar 18; 95(6):1592-600. PubMed ID: 9118530
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.